Skip to main content

Table 1 Baseline patient demographics and clinical characteristics of patients receiving olanzapine long-acting injection

From: Baseline characteristics and hospitalizations in patients with schizophrenia receiving olanzapine long-acting injection: an interim analysis from a non-interventional, prospective observational safety study

Characteristic

All Patients with ≥1 Injection (N = 668)

Age (years), mean (SD)

40.8 (11.8)

Gender, n (%)

 

 Male

413 (61.8)

 Female

255 (38.2)

Race, n (%)

 

 Black

9 (1.3)

 Asian

4 (0.6)

 White

623 (93.3)

 Missing

32 (4.8)

Weight (kg), mean (SD)

79.4 (17.2)a

Age at first episode of schizophrenia (years), mean (SD)

29.2 (10.0)

Psychiatric hospitalization, prior 12 months

 

 Yes, n (%)

321 (48.1)

 Number of days (mean, SD)

39.1 (81.6)

 Number of days – among only patients with a hospitalization (mean, SD)

81.4 (102.2)

Psychiatric hospitalization, prior 6 months

 

 Yes, n (%)

289 (43.3)

 Number of days (mean, SD)

24.3 (46.1)

 Number of days – among only patients with a hospitalization (mean, SD)

56.2 (56.0)

Antipsychotic treatment previous 2 years

 

 Yes, n (%)

590 (88.3)

  1. Abbreviations: N/n number of patients, SD standard deviation
  2. aFive patients were missing from the analysis